EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
ramusmedical
Europe

Minoryx Therapeutics announces dosing of first US patient in phase 2/3 clinical study of MIN-102 (ADVANCE)

ADVANCE trial recruitment is progressing rapidly in Europe with over 50 percent X-ALD patients enrolled  Mataró, Barcelona, Spain, September 5, 2018- Minoryx Therapeu...
5 September 2018 Europe | news | North America | Regional News
Continue Reading →
Europe

Thrombolytic Science Initiates Phase 2 Clinical Trial of its Novel Treatment Regimen for Ischemic Stroke

Study Seeks to Confirm Efficacy and Safety of Next-generation Clot-dissolving Therapy Consisting of Low-dose tPA and HisproUK Cambridge, Mass., USA, September 05, 201...
5 September 2018 Europe | news | Regional News
Continue Reading →
Europe

Novartis receives EC approval for Kymriah to treat two cancers

The European Commission (EC) has granted approval for Novartis’ Kymriah to treat patients with B-cell acute lymphoblastic leukaemia (ALL) and diffuse large B-cell lym...
30 August 2018 Europe | news | Regional News
Continue Reading →
Europe

Vistusertib and paclitaxel combination shrinks tumours in trial

An early clinical trial conducted by UK researchers has demonstrated positive profile for the use of vistusertib and paclitaxel combination to treat ovarian and lung...
30 August 2018 Europe | news | Regional News
Continue Reading →
Europe

Ascom and Dräger introduce integrated clinical alarm management solution in North America to improve patient care

The full integration of Ascom Unite Connect for clinical systems with Dräger Infinity patient monitoring systems will deliver mobile alert message notifications, cus...
28 August 2018 Europe | news | Regional News
Continue Reading →
Europe

Ozempic® consistently reduced the risk of major cardiovascular events across type 2 diabetes populations at high CV risk regardless of prior CV events at baseline

Munich, Germany, 26 August 2018 ­- Ozempic® (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack...
28 August 2018 Europe | news | Regional News
Continue Reading →
Europe

Pfizer begins pivotal phase 3 program for investigational hemophilia B gene therapy

Pfizer and Spark Therapeutics announced that Pfizer initiated a Phase 3 open-label, multi-center, lead-in study (NCT03587116) to evaluate the efficacy and safety of c...
28 August 2018 Europe | news | Regional News
Continue Reading →
Europe

Boehringer, Lilly diabetes drug Tradjenta succeeds in cardiovascular outcome trial

 Boehringer Ingelheim and Eli Lilly and Company reported that the CARMELINA cardiovascular outcome trial evaluating their diabetes drug Tradjenta met its primary ...
28 August 2018 Europe | news | Regional News
Continue Reading →
Europe

New research finds significant link between high Omega-3 Index and depression

New research published in the August edition of the Journal of the American College of Cardiology's Heart Failure issue found significant correlations between blood l...
28 August 2018 Europe | news | Regional News
Continue Reading →
Europe

CPhI Annual Report expert warns ‘innovation is being hindered by regulators’

CPhI Panel member Girish Malhotra, President at EPCOT International, writes that pharma's future is putting innovations in the hands of innovators, not regulators - b...
24 August 2018 Europe | news
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte